EpiPen Maker Mylan Faces Federal Antitrust Investigator


Federal antitrust regulators are eyeing big drugmaker Mylan’s EpiPen business, the company said this week.

Mylan, in a statement, said the Federal Trade Commission asked it “months ago” for information about its anti-allergy EpiPen “as part of a preliminary investigation.”

The disclosure comes nearly five months after two United States senators asked the FTC to investigate whether Mylan violated antitrust laws to protect the auto-injector EpiPen from competition.

This reminds me of the pharmaceutical company executive who…

“The drug, called Daraprim, was acquired in August by Turing Pharmaceuticals, a start-up run by a former hedge fund manager. Turing immediately raised the price to $750 a tablet from $13.50, bringing the annual cost of treatment for some patients to hundreds of thousands of dollars.”



“Pharma bro Martin Shkreli in court as securities fraud case moves closer to trial”

Few things get my goat more than price gouging.

I imagine there are those who feel that someone is entitled to charge whatever they want for a good or service.

DISCLAIMER: The views and opinions expressed in these forums do not necessarily reflect those of Catholic Answers. For official apologetics resources please visit www.catholic.com.